Immunosuppression in Peripheral Neuropathy: Rationale and Reality

IJ Sutton, John Winer

Research output: Contribution to journalArticle

4 Citations (Scopus)


Plasma exchange, intravenous immunoglobulin and corticosteroids continue to be the mainstay of treatment for inflammatory neuropathies. Recent trials demonstrate that combining these therapies is not significantly more effective than single agent treatment. The usefulness of novel immunotherapies and cytotoxic agents is difficult to ascertain because of the treatment of small numbers of patients in open-label studies.
Original languageEnglish
Pages (from-to)291-295
Number of pages5
JournalCurrent Opinion in Pharmacology
Issue number3
Publication statusPublished - 1 Jun 2002


Dive into the research topics of 'Immunosuppression in Peripheral Neuropathy: Rationale and Reality'. Together they form a unique fingerprint.

Cite this